3 imaging modality sales specialist jobs found

Job Title Sales, District Modality Leader- Computed Tomography (Rocky Mountain/Pac West) Job Description Sales, District Modality Leader- Computed Tomography (Rocky Mountain/Pac West) The District Modality Leader (DML) for Computed Tomography is the knowledge expert on CT product sales and positioning across their assigned district. Operating as a franchise owner, the DML drives overall modality strategy, provides deep clinical and technical expertise across all accounts in the territory, and develops individualized plans for each Imaging Account Manager (IAM) to maximize market visibility, market share, and revenue growth. This role requires exceptional ability to lead, influence, and hold cross-functional peers accountable without direct management authority. Preferred location- greater Seattle market, followed by greater Denver area. Your role: Own the CT business for the district, driving orders, revenue growth, market share, and margin performance....

Job Title Sales, District Modality Leader- Computed Tomography (Midwest) Job Description Sales, District Modality Leader- Computed Tomography (Midwest) The District Modality Leader (DML) for Computed Tomography is the knowledge expert on CT product sales and positioning across their assigned district. Operating as a franchise owner, the DML drives overall modality strategy, provides deep clinical and technical expertise across all accounts in the territory, and develops individualized plans for each Imaging Account Manager (IAM) to maximize market visibility, market share, and revenue growth. This role requires exceptional ability to lead, influence, and hold cross-functional peers accountable without direct management authority. This territory will include: SD/ND/MN/IA/WI/IL. Preferred location- greater Chicago market, followed by greater Twin Cities area. Your role: Own the CT business for the district, driving orders, revenue growth, market share, and...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...